SUTRO BIOPHARMA, INC. (STRO) scores 66 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is 38.06, representing a 58% margin of safety. Quantitative score: 58/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.